A detailed history of Generali Asset Management Spa Sgr transactions in Moderna, Inc. stock. As of the latest transaction made, Generali Asset Management Spa Sgr holds 59,895 shares of MRNA stock, worth $1.53 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
59,895
Holding current value
$1.53 Million
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$28.35 - $47.53 $1.7 Million - $2.85 Million
59,895 New
59,895 $1.7 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Generali Asset Management Spa Sgr Portfolio

Follow Generali Asset Management Spa Sgr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generali Asset Management Spa Sgr, based on Form 13F filings with the SEC.

News

Stay updated on Generali Asset Management Spa Sgr with notifications on news.